The use of post-ERCP pancreatitis prophylaxis and recognition of risk factors for post-ERCP pancreatitis among Dutch gastroenterologists: a nationwide practice survey

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON22181

Enrollment

150

Registered

2020-03-30

Start date

2020-01-19

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-ERCP pancreatitis

Interventions

Online survey

Eligibility

Inclusion criteria

Inclusion criteria: BIG-registered physician specialized in gastroenterology

Exclusion criteria

Exclusion criteria: 1. Non- gastroenterology physicians 2. Residents

Design outcomes

Primary

Measure	Time frame
The primary outcome measure of this survey is exploration of the use and attitudes towards various forms of post-ERCP prophylaxis (NSAID use, prophylactic PD-stenting and IV hyperhydration) amongst Dutch biliary endoscopists.	—

Secondary

Measure	Time frame
1. Risk factor recognition for the development of post-ERCP pancreatitis 2. Guideline adherence to the 2019 ESGE Guidelines ‘ERCP related adverse events’ 3. The presence and content of a post-ERCP pancreatitis prophylaxis protocol 4. Longitudinal comparison of answers from 2013 survey on the same subject by Dutch Pancreatitis Study Group (DPSG)	—

Contacts

Public ContactChrista Sperna Weiland

Radboudumc

christa.spernaweiland@radboudumc.nl0883207054

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)